Bile Salt Stabilized Vesicles (Bilosomes): A Novel Nano-Pharmaceutical Design for Oral Delivery of Proteins and Peptides.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Current pharmaceutical design

• Publication date

  2017-02-28

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.2174/1381612823666170124111142PMID 28120725
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Multifaceted applications of bile salts in pharmacy: an emphasis on nanomedicine

  2015cited by this paper
• Niosomal carriers enhance oral bioavailability of carvedilol: effects of bile salt-enriched vesicles and carrier surface charge

  2015cited by this paper
• Proliposomes containing a bile salt for oral delivery of Ginkgo biloba extract: Formulation optimization, characterization, oral bioavailability and tissue distribution in rats.

  2015cited by this paper
• Improvement of oral availability of ginseng fruit saponins by a proliposome delivery system containing sodium deoxycholate

  2015cited by this paper
• Enhanced oral absorption of insulin-loaded liposomes containing bile salts: a mechanistic study.

  2014cited by this paper
• Oral mucosal immunization using glucomannosylated bilosomes.

  2014cited by this paper
• Improved stability and immunological potential of tetanus toxoid containing surface engineered bilosomes following oral administration.

  2014cited by this paper
• Integrity and stability of oral liposomes containing bile salts studied in simulated and ex vivo gastrointestinal media.

  2013cited by this paper
• Recombinant Baculovirus Associated with Bilosomes as an Oral Vaccine Candidate against HEV71 Infection in Mice

  2013cited by this paper
• Approaches for enhancing oral bioavailability of peptides and proteins.

  2013cited by this paper
• Oral delivery of therapeutic protein/peptide for diabetes--future perspectives.

  2013cited by this paper
• Hypoglycemic activity and oral bioavailability of insulin-loaded liposomes containing bile salts in rats: the effect of cholate type, particle size and administered dose.

  2012cited by this paper
• Models to predict intestinal absorption of therapeutic peptides and proteins.

  2012cited by this paper
• Significant systemic and mucosal immune response induced on oral delivery of diphtheria toxoid using nano‐bilosomes

  2011cited by this paper
• Stability of liposomes containing bio-enhancers and tetraether lipids in simulated gastro-intestinal fluids.

  2011cited by this paper
• Polyamidoamine dendrimers as novel potential absorption enhancers for improving the small intestinal absorption of poorly absorbable drugs in rats.

  2011cited by this paper
• How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?

  2010cited by this paper
• Pharmacological effect of orally delivered insulin facilitated by multilayered stable nanoparticles.

  2010cited by this paper
• Cellular evaluation of synthesized insulin/transferrin bioconjugates for oral insulin delivery using intelligent complexation hydrogels.

  2010cited by this paper
• Polymer integrity related absorption mechanism of superporous hydrogel containing interpenetrating polymer networks for oral delivery of insulin.

  2010cited by this paper
• Enteric-coated capsules filled with freeze-dried chitosan/poly(gamma-glutamic acid) nanoparticles for oral insulin delivery.

  2010cited by this paper
• Enhanced bioavailability of the poorly water-soluble drug fenofibrate by using liposomes containing a bile salt.

  2009cited by this paper
• Lipid vesicle size of an oral influenza vaccine delivery vehicle influences the Th1/Th2 bias in the immune response and protection against infection.

  2009cited by this paper
• Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery.

  2009cited by this paper
• Improving oral absorption of Salmon calcitonin by trimyristin lipid nanoparticles.

  2009cited by this paper
• Importance of intermolecular interaction on the improvement of intestinal therapeutic peptide/protein absorption using cell-penetrating peptides.

  2009cited by this paper
• Liposomal formulations of glucagon-like peptide-1: improved bioavailability and anti-diabetic effect.

  2009cited by this paper
• Therapeutic application of peptides and proteins: parenteral forever?

  2009cited by this paper
• Barrier properties of mucus.

  2009cited by this paper
• Preparation and evaluation of an oral delivery system for time-dependent colon release of insulin and selected protease inhibitor and absorption enhancer compounds.

  2009cited by this paper
• Oral immunization against hepatitis B using bile salt stabilized vesicles (bilosomes).

  2008cited by this paper
• Past, present, and future technologies for oral delivery of therapeutic proteins.

  2008cited by this paper
• In vitro and in vivo study of N-trimethyl chitosan nanoparticles for oral protein delivery.

  2008cited by this paper
• Correlation of in vitro and in vivo models for the oral absorption of peptide drugs

  2008cited by this paper
• In Vitro Studies are Sometimes Better than Conventional Human Pharmacokinetic In Vivo Studies in Assessing Bioequivalence of Immediate-Release Solid Oral Dosage Forms

  2008cited by this paper
• Multi-ion-crosslinked nanoparticles with pH-responsive characteristics for oral delivery of protein drugs.

  2008cited by this paper
• Protein and Peptide Drug Delivery: Oral Approaches

  2008cited by this paper
• Polyelectrolyte nanoparticles with high drug loading enhance the oral uptake of hydrophobic compounds.

  2006cited by this paper
• Oral delivery of tetanus toxoid using vesicles containing bile salts (bilosomes) induces significant systemic and mucosal immunity.

  2006cited by this paper
• Is the oral route possible for peptide and protein drug delivery?

  2006cited by this paper
• Why is it Challenging to Predict Intestinal Drug Absorption and Oral Bioavailability in Human Using Rat Model

  2006cited by this paper
• Preparation and characterization of insulin nanoparticles employing chitosan and poly(methylmethacrylate/methylmethacrylic acid) copolymer.

  2006cited by this paper
• Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: preparation, in vitro characterization and in vivo evaluation.

  2006cited by this paper
• Exploring the role of different drug transport routes in permeability screening.

  2005cited by this paper
• Protein drug stability: a formulation challenge

  2005cited by this paper
• Region-Dependent Role of the Mucous/Glycocalyx Layers in Insulin Permeation Across Rat Small Intestinal Membrane

  2005cited by this paper
• Keynote review: intestinal Peyer's patch M cells and oral vaccine targeting.

  2005cited by this paper
• Poly (lactide-co-glycolide) particles of different physicochemical properties and their uptake by peyer's patches in mice.

  2005cited by this paper
• Cell culture-based models for intestinal permeability: a critique.

  2005cited by this paper
• The vagina as a route for systemic drug delivery.

  2005cited by this paper
• Cholera toxin B subunit conjugated bile salt stabilized vesicles (bilosomes) for oral immunization.

  2004cited by this paper
• Optimisation of a lipid based oral delivery system containing A/Panama influenza haemagglutinin.

  2004cited by this paper
• The Effect of Different Lipid Components on the In Vitro Stability and Release Kinetics of Liposome Formulations

  2004cited by this paper
• Cellular Uptake But Low Permeation of Human Calcitonin-Derived Cell Penetrating Peptides and Tat(47-57) Through Well-Differentiated Epithelial Models

  2004cited by this paper
• Principles of transmucosal delivery of therapeutic agents.

  2004cited by this paper
• The effect of various liposome formulations on insulin penetration across Caco-2 cell monolayer.

  2004cited by this paper
• Permeation enhancing polymers in oral delivery of hydrophilic macromolecules: thiomer/GSH systems.

  2003cited by this paper
• Challenges for the oral delivery of macromolecules

  2003cited by this paper
• Emerging trends in oral delivery of peptide and protein drugs.

  2003cited by this paper
• Preparation and evaluation of proliposomes containing salmon calcitonin.

  2002cited by this paper
• Oral delivery of proteins: progress and prognostication.

  2002cited by this paper
• The Role of Lymphatic Transport in Enhancing Oral Protein and Peptide Drug Delivery

  2002cited by this paper
• Oral immunisation with peptide and protein antigens by formulation in lipid vesicles incorporating bile salts (bilosomes).

  2001cited by this paper
• Current methodologies used for evaluation of intestinal permeability and absorption.

  2000cited by this paper
• Expression of specific markers and particle transport in a new human intestinal M-cell model.

  2000cited by this paper
• MDCK (Madin-Darby canine kidney) cells: A tool for membrane permeability screening.

  1999cited by this paper
• Transport of human growth hormone across Caco-2 cells with novel delivery agents: evidence for P-glycoprotein involvement.

  1999cited by this paper
• Effect of formulation on the systemic absorption of insulin from enhancer-free ocular devices.

  1999cited by this paper
• Dodecylphosphocholine-mediated enhancement of paracellular permeability and cytotoxicity in Caco-2 cell monolayers.

  1999cited by this paper
• Increasing drug solubility by means of bile salt-phosphatidylcholine-based mixed micelles.

  1998cited by this paper
• Modification of a phospholipid stabilized emulsion interface by bile salt: effect on pancreatic lipase activity.

  1998cited by this paper
• The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins.

  1998cited by this paper
• Conversion by Peyer's patch lymphocytes of human enterocytes into M cells that transport bacteria.

  1997cited by this paper
• Oral Controlled Release Technology for Peptides: Status and Future Prospects

  1996cited by this paper
• Systemic delivery of peptides and proteins across absorptive mucosae.

  1996cited by this paper
• HT29-MTX/Caco-2 cocultures as an in vitro model for the intestinal epithelium: in vitro-in vivo correlation with permeability data from rats and humans.

  1996cited by this paper
• Tight junctions and the molecular basis for regulation of paracellular permeability.

  1995cited by this paper
• Absorption characteristics of chemically modified-insulin derivatives with various fatty acids in the small and large intestine.

  1995cited by this paper
• Hydrogel-Based lontotherapeutic Delivery Devices for Transdermal Delivery of Peptide/Protein Drugs

  1993cited by this paper
• Mediation of trypsin inhibitor-induced pancreatic hypersecretion by secretin and cholecystokinin in rats.

  1992cited by this paper
• Cell cultures as models for drug absorption across the intestinal mucosa.

  1991cited by this paper
• Transport of peptide and protein drugs across biological membranes

  1990cited by this paper
• Absorption of peptides and proteins from the respiratory tract and the potential for development of locally administered vaccine.

  1990cited by this paper
• Intestinal Aspects of Lipid Absorption: In Review

  1989cited by this paper
• Cyclosporine.

  1989cited by this paper
• Intestinal drug absorption enhancement: an overview.

  1989cited by this paper
• Enzymatic barriers to peptide and protein absorption.

  1988cited by this paper
• In Vitro Measurement of Gastrointestinal Tissue Permeability Using a New Diffusion Cell

  1988cited by this paper
• Studies on the mechanism of bile salt-induced liposomal membrane damage.

  1983cited by this paper
• Permeability properties of phospholipid membranes: effect of cholesterol and temperature.

  1972cited by this paper

• Optimized nano-bilosomes loaded ocular insert as a promising approach for boosting voriconazole ocular bioavailability: In-vitro, microbiological, and in-vivo assessments

  2026cites this paper
• Targeted neurotherapy: evaluating olanzapine-loaded bilosomes in a cuprizone-induced schizophrenia model.

  2025cites this paper
• Fabrication and appraisal of targeted axitinib loaded bilosomes for the enhanced breast and ovarian anticancer activity

  2025cites this paper
• Bilosomes: An Emerging Vesicular Carrier for Enhanced Drug Delivery

  2025cites this paper
• Lipid-based nanostructures in targeted management of neurological disorders: a comprehensive review.

  2025cites this paper
• Formulation and evaluation of trametinib loaded novel nano elastic carriers for treatment of melanoma

  2025cites this paper
• Nanobilosome as custom-tailored modality in addressing Alzheimer’s disease: advancements and translational glitches

  2025cites this paper
• Vesicular Carriers for Phytochemical Delivery: A Comprehensive Review of Techniques and Applications

  2025cites this paper
• The Pharmaceutical and Pharmacological Potential Applications of Bilosomes as Nanocarriers for Drug Delivery

  2025cites this paper
• Development of biomaterials for bone tissue engineering based on bile acids

  2025cites this paper
• Nanotechnology-based Approaches for Targeted Drug Delivery to the Small Intestine: Advancements and Challenges.

  2025cites this paper
• Neuroprotective efficiency of celecoxib vesicular bilosomes for the management of lipopolysaccharide-induced Alzheimer in mice employing 23 full factorial design

  2024cites this paper
• Unveiling the role of nanoparticle-based therapeutic strategies for pulmonary drug delivery

  2024cites this paper
• Bilosome as a potential carrier for improving poor oral drug bioavailability

  2024cites this paper
• Bilosomes and Niosomes for Enhanced Intestinal Absorption and In Vivo Efficacy of Cytarabine in Treatment of Acute Myeloid Leukemia

  2024cites this paper
• Effective tailoring of cefepime into bilosomes: A promising nanoplatform for enhancing oral absorption, extending half-life, and evaluating biocompatibility, antibacterial, anti-biofilm, anti-breast cancer activity, ex-vivo, and in-vivo studies.

  2024cites this paper
• Enhancing Nutraceutical Bioavailability with Bilosomes: A Comprehensive Review

  2024cites this paper
• Effect of formulation variables on drug release from bilosomes; effect of cholesterol concentration

  2024cites this paper
• Emerging Trends in Bilosomes as Therapeutic Drug Delivery Systems

  2024cites this paper
• Bilosomes As Oral Drug Delivery Carrier

  2024cites this paper
• Bile salts: unlocking the potential as bio-surfactant for enhanced drug absorption

  2024cites this paper
• Unravelling the in vivo dynamics of liposomes: Insights into biodistribution and cellular membrane interactions.

  2024cites this paper
• Therapeutic Peptides and Proteins: Stabilization Challenges and Biomedical Applications by Means of Nanodelivery Systems

  2024cites this paper
• Enhanced Oral Bioavailability of Progesterone in Bilosome Formulation: Fabrication, Statistical Optimization, and Pharmacokinetic Study

  2024cites this paper
• Novel vesicular bilosomal delivery systems for dermal/transdermal applications.

  2023cites this paper
• Triterpenes Drug Delivery Systems, a Modern Approach for Arthritis Targeted Therapy

  2023cites this paper
• Vesicle-Encapsulated Rolipram (PDE4 Inhibitor) and Its Anticancer Activity.

  2023cites this paper
• Development, optimization, and assessment of losartan nano-bilosomes to mitigate diabetes-induced microvascular complications in Sprague Dawley rats

  2023cites this paper
• Oral insulin delivery: Barriers, strategies, and formulation approaches: A comprehensive review.

  2023cites this paper
• Bilosomes as Soft Nanovesicular Carriers for Ropinirole Hydrochloride: Preparation and In- vitro Characterization

  2023cites this paper
• Bilosomes and Biloparticles for the Delivery of Lipophilic Drugs: A Preliminary Study

  2023cites this paper
• Nano-scale drug delivery systems for luteolin: advancements and applications.

  2023cites this paper
• Pegylated bilosomes for improvement of oral delivery of Biochanin A: Development to preclinical evaluation

  2023cites this paper
• Vesicular drug delivery systems for oral absorption enhancement

  2023cites this paper
• Effects of Different Types of Bile Salts on the Physical Properties of Ropinirole-Loaded

  2023cites this paper
• Pitavastatin-loaded bilosomes for oral treatment of hepatocellular carcinoma: a repurposing approach

  2022cites this paper
• Versatile Oral Insulin Delivery Nanosystems: From Materials to Nanostructures

  2022cites this paper
• Exploring the impact of physicochemical properties of liposomal formulations on their in vivo fate.

  2022cites this paper
• BILOSOMES AS NON-INVASIVE DRUG DELIVERY SYSTEM

  2022cites this paper
• Aquasomes: Advanced vesicular-based nanocarrier systems.

  2022cites this paper
• Bilosomes as Nanoplatform for Oral Delivery and Modulated In Vivo Antimicrobial Activity of Lycopene

  2022cites this paper
• Bile salt stabilized nanovesicles as a promising drug delivery technology: A general overview and future perspectives

  2022cites this paper
• Bioactive Apigenin loaded oral nano bilosomes: Formulation optimization to preclinical assessment

  2021cites this paper
• Nanopharmaceuticals: Principles and Applications Vol. 2

  2021cites this paper
• Development of an Icariin-Loaded Bilosome-Melittin Formulation with Improved Anticancer Activity against Cancerous Pancreatic Cells

  2021cites this paper
• Recent progress in nanotechnology-based drug carriers for celastrol delivery.

  2021cites this paper
• Obstructions in Nanoparticles Conveyance, Nano-Drug Retention, and EPR Effect in Cancer Therapies

  2021cites this paper
• Advancement in design of nanostructured lipid carriers for cancer targeting and theranostic application.

  2021cites this paper
• Piceatannol-Loaded Bilosome-Stabilized Zein Protein Exhibits Enhanced Cytostatic and Apoptotic Activities in Lung Cancer Cells

  2021cites this paper
• Advanced trends in protein and peptide drug delivery: a special emphasis on aquasomes and microneedles techniques

  2020cites this paper
• Oral Insulin Delivery Using Poly (Styrene Co-Maleic Acid) Micelles in a Diabetic Mouse Model

  2020cites this paper
• Recent Advances of Nanocarriers for Effective Delivery of Therapeutic Peptides

  2020cites this paper
• Recent Advances on Nanostructured Materials for Drug Delivery and Release

  2020cites this paper
• Phytochemical delivery through nanocarriers: a review.

  2020cites this paper
• Development and evaluation of a lyophilized product containing insulin

  2020influential citation
• Insight into the in vivo translocation of oral liposomes by fluorescence resonance energy transfer effect.

  2020cites this paper
• Molecular docking and statistical optimization of taurocholate-stabilized galactose anchored bilosomes for the enhancement of sofosbuvir absorption and hepatic relative targeting efficiency

  2020cites this paper
• The Scope and Challenges of Vesicular Carrier-mediated Delivery of Docetaxel for the Management of Cancer.

  2020cites this paper
• Characterization, Optimization, In Vitro and In Vivo Evaluation of Simvastatin Proliposomes, as a Drug Delivery

  2020cites this paper
• Bilosomes nanocarriers for improved oral bioavailability of acyclovir: A complete characterization through in vitro, ex-vivo and in vivo assessment

  2020cites this paper
• Advanced trends in protein and peptide drug delivery: a special emphasis on aquasomes and microneedles techniques

  2020cites this paper
• Nanomaterials Used for Delivery of Bioactives

  2020cites this paper
• Biomimetic and bioinspired strategies for oral drug delivery.

  2020cites this paper
• Glucose‐linked sub‐50‐nm unimer polyion complex‐assembled gold nanoparticles for targeted siRNA delivery to glucose transporter 1‐overexpressing breast cancer stem‐like cells

  2019cites this paper
• Cilnidipine loaded transfersomes for transdermal application: Formulation optimization, in-vitro and in-vivo study

  2019cites this paper
• Hyaluronic acid-functionalized bilosomes for targeted delivery of tripterine to inflamed area with enhancive therapy on arthritis

  2019cites this paper
• Smart pH-responsive polymeric micelles for programmed oral delivery of insulin.

  2019cites this paper
• Nanovesicles for Nanomedicine: Theory and Practices.

  2019cites this paper
• Anionic versus cationic bilosomes as oral nanocarriers for enhanced delivery of the hydrophilic drug risedronate.

  2019cites this paper
• Use of Polymers in Controlled Release of Active Agents

  2019cites this paper
• Design of novel proliposome formulation for antioxidant peptide, glutathione with enhanced oral bioavailability and stability

  2019cites this paper
• Chitosan-Coated Nanoparticles: Effect of Chitosan Molecular Weight on Nasal Transmucosal Delivery

  2019cites this paper
• Emerging transporter-targeted nanoparticulate drug delivery systems

  2018cites this paper
• Recent advancements in oral administration of insulin‐loaded liposomal drug delivery systems for diabetes mellitus

  2018cites this paper
• Temozolomide loaded nano lipid based chitosan hydrogel for nose to brain delivery: Characterization, nasal absorption, histopathology and cell line study.

  2018cites this paper
• Frontier Views in Designing Therapeutic Candidates for Management of Diverse Diseases

  2018cites this paper
• Nanocarrier-Mediated Therapeutic Protein Delivery

  2018cites this paper
• Development and optimization of sulforaphane-loaded nanostructured lipid carriers by the Box-Behnken design for improved oral efficacy against cancer: in vitro, ex vivo and in vivo assessments

  2018cites this paper
• Editorial: Frontier Views in Designing Therapeutic Candidates for Management of Diverse Diseases.

  2017cites this paper
• Exosomes in bile as potential pancreatobiliary tumor biomarkers

  2017cites this paper